Man-Tzu Wang
Rapt Therapeutics (United States)(US)UPMC Hillman Cancer Center(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, RNA modifications and cancer, Pancreatic and Hepatic Oncology Research, Cancer-related molecular mechanisms research, Prostate Cancer Treatment and Research
Most-Cited Works
- → K-Ras Promotes Tumorigenicity through Suppression of Non-canonical Wnt Signaling(2015)190 cited
- → Human Pregnane X Receptor and Resistance to Chemotherapy in Prostate Cancer(2007)131 cited
- → Impairment of mitochondrial respiration in mouse fibroblasts byoncogenic H-RASQ61L(2010)52 cited
- → Abstract 3424: Cancer cells lose their expression of lipoxygenases in order to activate pro-survival and angiogenic pathways thereby establishing successful macro-metastases(2012)7 cited
- → Oncogenic KRAS promotes pancreatic ductal adenocarcinoma (PDAC) through post-transcriptionally regulated KRAS-induced granules (KGs)(2023)3 cited
- → Cancer Stem Cells in Resistance to Cytotoxic Drugs: Implications in Chemotherapy(2013)2 cited
- → Abstract 4970: The role of POU5F1B in prostate cancer(2014)1 cited
- → Abstract 2277: Machine learning to identify prostate cancer mutations for screening cell-free DNA (cfDNA)(2018)1 cited
- → Abstract 1866: Discovery of mutation-independent EGFR degrading bispecific antibodies that suppress tumor growth in preclinical tumor models(2024)1 cited
- → Abstract 7465: Leukemia inhibitory factor creates an immune suppressive tumor microenvironment and fosters tumor growth in KRAS-driven pancreatic ductal adenocarcinoma(2024)